BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 217 filers reported holding BLUEPRINT MEDICINES CORP in Q1 2020. The put-call ratio across all filers is 0.91 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $271,327,204 | +14.5% | 2,517,417 | +0.8% | 8.17% | +35.7% |
Q1 2024 | $237,002,777 | -10.8% | 2,498,448 | -13.3% | 6.02% | -8.0% |
Q4 2023 | $265,795,740 | +97.1% | 2,881,567 | +7.3% | 6.54% | +81.1% |
Q3 2023 | $134,855,465 | -2.4% | 2,685,294 | +22.8% | 3.61% | +9.9% |
Q2 2023 | $138,197,670 | +51.1% | 2,186,672 | +7.6% | 3.29% | +50.7% |
Q1 2023 | $91,466,830 | +10.4% | 2,033,048 | +7.5% | 2.18% | +9.4% |
Q4 2022 | $82,867,053 | -18.2% | 1,891,510 | +23.0% | 1.99% | -23.8% |
Q3 2022 | $101,352,000 | +104.9% | 1,538,195 | +57.1% | 2.62% | +81.9% |
Q2 2022 | $49,458,000 | -18.3% | 979,174 | +3.3% | 1.44% | -5.6% |
Q1 2022 | $60,540,000 | -34.3% | 947,715 | +10.2% | 1.52% | -28.4% |
Q4 2021 | $92,088,000 | +5.4% | 859,755 | +1.2% | 2.13% | +15.8% |
Q3 2021 | $87,353,000 | +22.8% | 849,659 | +5.0% | 1.84% | +30.7% |
Q2 2021 | $71,147,000 | -2.0% | 808,860 | +8.3% | 1.41% | -11.2% |
Q1 2021 | $72,605,000 | -23.1% | 746,732 | -11.3% | 1.58% | -20.9% |
Q4 2020 | $94,430,000 | +6.9% | 842,000 | -11.6% | 2.00% | -10.7% |
Q3 2020 | $88,322,000 | +17.9% | 952,773 | -0.8% | 2.24% | +9.1% |
Q2 2020 | $74,882,000 | +73.7% | 960,029 | +30.3% | 2.05% | +15.3% |
Q1 2020 | $43,100,000 | +40.8% | 737,000 | +92.9% | 1.78% | +84.3% |
Q4 2019 | $30,602,000 | +24.9% | 382,000 | +14.5% | 0.97% | -0.9% |
Q3 2019 | $24,502,000 | -15.5% | 333,500 | +8.5% | 0.98% | -7.0% |
Q2 2019 | $29,006,000 | +31.8% | 307,500 | +11.8% | 1.05% | +23.6% |
Q1 2019 | $22,014,000 | +91.1% | 275,000 | +28.7% | 0.85% | +56.1% |
Q4 2018 | $11,518,000 | -26.2% | 213,658 | +6.8% | 0.54% | -3.7% |
Q3 2018 | $15,612,000 | +23.6% | 200,000 | +0.5% | 0.56% | +16.3% |
Q2 2018 | $12,633,000 | -12.7% | 199,000 | +26.1% | 0.49% | -21.2% |
Q1 2018 | $14,466,000 | +30.9% | 157,753 | +7.7% | 0.62% | +23.2% |
Q4 2017 | $11,048,000 | +83.3% | 146,500 | +69.4% | 0.50% | +80.2% |
Q3 2017 | $6,026,000 | – | 86,500 | – | 0.28% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Foresite Capital Management III, LLC | 559,381 | $41,098,000 | 15.69% |
Casdin Capital, LLC | 940,000 | $69,061,800,000 | 7.15% |
Ghost Tree Capital, LLC | 325,000 | $23,878,000 | 6.08% |
CADIAN CAPITAL MANAGEMENT, LP | 1,418,704 | $104,232,000 | 4.96% |
DAFNA Capital Management LLC | 123,218 | $9,053,000 | 3.40% |
BVF INC/IL | 437,565 | $32,148,000 | 3.38% |
Opaleye Management Inc. | 105,000 | $7,714,000 | 2.79% |
Cormorant Asset Management, LP | 493,000 | $36,221,000 | 2.20% |
Novo Holdings A/S | 170,667 | $12,539,000 | 2.15% |
Artal Group S.A. | 600,000 | $44,082,000 | 1.77% |